Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
about
Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trendsPopulation-based epidemiology and microbiology of community-onset bloodstream infectionsPrevention of sepsis prior to prostate biopsyPatient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia.Salmonella enterica bacteraemia: a multi-national population-based cohort studyClinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae.Bacteremia complicating gram-negative urinary tract infections: a population-based study.Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolatesForeign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998-2007Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study.External validation of bloodstream infection mortality risk score in a population-based cohort.Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteriaHost factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice.Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.The clinical impact of fluoroquinolone resistance in patients with E coli bacteremiaMolecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian regionAntibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsyDelayed Occurrence of Escherichia coli Subdural Empyema Following Head Injury in an Elderly Patient: A Case Report and Literature Review.Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremiaIncidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.Asthma and risk of non-respiratory tract infection: a population-based case-control study.Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.Gender specific differences in the immune response to infection.Escherichia coli pyomyositis in an immunocompromised host.Reducing infection rates after prostate biopsy.Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage.Molecular screening of virulence genes in extraintestinal pathogenic Escherichia coli isolated from human blood culture in Brazil.Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study.Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada.Microbiological risk assessment for personal care products.Asthma, other atopic conditions and risk of infections in 105 519 general population never and ever smokers.Risk factors of mortality in bloodstream infections caused by Klebsiella pneumonia: A single-center retrospective study in China.Shorter leukocyte telomere length is associated with higher risk of infections: a prospective study of 75,309 individuals from the general population.
P2860
Q27007026-5D85F854-C255-4D25-B8DD-3CEE9E209725Q27013639-63872ED2-B67C-47A8-917D-063A096824A4Q28071808-C3A517B4-C821-46F9-A2D0-6213C841CE08Q31047716-AA1C0320-1CCA-487E-942C-C21E2160C293Q33467124-E88300AD-4CAA-46F1-A524-0C6A29CC8AF2Q33557559-F43CB0CD-5CC7-4EEE-8BF1-C4537849D988Q33566287-6CB223F1-C9BE-44BE-B918-F0245CF45D9DQ33738237-57A8FFFE-75BA-4613-845F-D9F8410DDFFCQ33769703-372EA7D6-D69A-4918-83FC-97FFD4366042Q34108669-C6AA4A78-06CA-44F0-85BB-492F04178954Q34274088-6EA8BB70-243F-46EE-9DEF-560A5766BCEBQ34494960-05A6D1F9-47FE-44F0-AA2F-B96B461D44ECQ34626330-DF7131F7-3627-41C8-94B3-148885EABA07Q34659183-F573BC04-BD72-4908-8243-876D8FCCB86EQ34741586-E2717D0A-7F6B-4872-81AA-B49AAD9CA7A0Q34876077-BCA37EDD-8A2E-43E5-BEB5-DA598E8DBBF3Q34960683-ACED9B81-2824-4818-BBE4-C5CF3F8CBA47Q34987739-2ECD823A-680F-4C2E-B98D-5F38286B47D7Q35164228-8CC38A7B-00AB-4D11-A784-1C06F3775182Q35689028-0C9DC8E2-0880-4B70-96C6-83B5D21DBD86Q35715463-E22C26CC-4CE0-432F-9360-65DF1F1CF93EQ35905272-50AFADC8-D217-4C9E-A1EB-E10F5C87585FQ36154990-4223085E-3E06-4DBB-B80E-C8B58742AC49Q36513085-F78973A5-44F1-4B75-B2AE-B8795D629628Q37217108-B938F894-F7E6-4A5C-8C76-43A9B87B6485Q37228984-CFE85BAC-907F-4A13-9BAC-D235A196A4A3Q37240953-8E7B3B72-E9ED-4409-A205-EE1AC4DFB8DAQ37247785-94BE2D8D-E7D6-4DD4-BF04-67CD440C0311Q37858452-3FA45201-7B51-4080-BA2D-7F84C437F3D1Q37993098-2CE5908D-C18D-40DE-BACE-D37C3C633E7DQ38178006-500513CC-75FB-43FF-9DF8-E011BFB97BACQ38848662-562D2527-8298-4E69-A728-A21D3D8457D3Q39199957-B4C19A09-CA83-41D2-84CA-074B4D423692Q39284005-AED63EAF-5FDC-414A-8026-21E53BCD4CB6Q39456487-08CC162C-49FF-4C05-AB48-30F8579DCEC4Q39640905-F3007E8E-5D96-4BF8-8FC7-0FC3DCA532E8Q39800031-F5C94404-A9CE-4F1E-8B80-2F5E799F28ADQ40055325-DBD15B30-E51B-4E2B-88AA-7F980E7ECC28Q40072899-08F2CBCA-9376-4EFE-B36A-AFF32165689AQ40206781-19641308-1DE5-4BAE-A1E2-17C326DCF969
P2860
Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Incidence, risk factors and ou ...... ns in a large Canadian region.
@en
Incidence, risk factors and ou ...... ns in a large Canadian region.
@nl
type
label
Incidence, risk factors and ou ...... ns in a large Canadian region.
@en
Incidence, risk factors and ou ...... ns in a large Canadian region.
@nl
prefLabel
Incidence, risk factors and ou ...... ns in a large Canadian region.
@en
Incidence, risk factors and ou ...... ns in a large Canadian region.
@nl
P2093
P1476
Incidence, risk factors and ou ...... ns in a large Canadian region.
@en
P2093
D B Gregson
D L Church
J D D Pitout
K B Laupland
P304
P356
10.1111/J.1469-0691.2008.02089.X
P577
2008-11-01T00:00:00Z